Douglas Flora: The research you’ve performed, and published is changing the way cancer patients are treated around the world
Douglas Flora shared a post by on LinkedIn:
“Patients are safer in our community because of work like this. Well done to our Center for Precision Medicine and Genomic Health.
The research you’ve performed, and published not only helped your patients, now is changing the way cancer patients are treated around the world. This is why we care so much about clinical research here.
And I must say, I love seeing your work mentioned on short lists academic powerhouses like Dana-Farber Cancer Institute.
‘The USA cancer community might be late to adopt Dihydropyrimidine dehydrogenase (DPYD) testing to avoid severe/fatal toxicity from commonly used chemotherapy, but the tide has finally changed. The recent Food and Drug Administration (FDA) package insert change is followed by very successful implementation at Dana-Farber Cancer Institute.
With data from community centers, such as Atrium Health and St. Elizabeth Healthcare, there are no more excuses for rest of the field.’ ”
See
Source: Douglas Flora/LinkedIn and
Dr. Douglas Flora, MD, is a medical oncologist based in Edgewood, Kentucky, with over 24 years of dedicated service in the field. Graduating from the Ohio State University College of Medicine in 1999, Dr. Flora has since become a respected figure in oncology, affiliated with leading hospitals such as St. Elizabeth Healthcare Edgewood-Covington Hospitals and St. Elizabeth Fort Thomas Hospital.
With a background in hematology and medical oncology, Dr. Flora serves as the Chief of the Division of Medical Oncology and Hematology at the TriHealth Cancer Institute in Cincinnati, Ohio. He specializes in treating various cancers, including breast, lung, and gastrointestinal malignancies, utilizing innovative treatment approaches backed by clinical research.
Beyond patient care, Dr. Flora is dedicated to medical education, mentoring future oncologists and contributing to research initiatives aimed at improving patient outcomes. His commitment to excellence and compassionate care underscores his significant impact in the fight against cancer.